Summarizing the evidence of respiratory transmission of mpox

NewsGuard 100/100 Score

A recent study published in The Lancet Microbe summarized the evidence for respiratory transmission of mpox.

Study: Mpox respiratory transmission: the state of the evidence. Image Credit: QINQIE99/Shutterstock
Study: Mpox respiratory transmission: the state of the evidence. Image Credit: QINQIE99/Shutterstock

Accelerated transmission of clade II mpox virus (MPXV) occurred in humans in 2022, resulting in thousands of cases globally. MPXV acquisition routes include percutaneous exposure (direct skin exposure), mucous membrane exposure (oral, vaginal, and rectal mucous membranes), and infectious virus particle inhalation.

Infection sources include humans, animals, and contaminated fomites. In the current mpox outbreak, the prevalence of anogenital lesions in cases suggests that sexual contact is the primary route of infection. In the present study, the authors described the evidence on MPXV respiratory transmission from studies conducted between 1961 and 2022.

Respiratory transmission of MPXV in animal models

Studies in non-human primates and prairie dogs have shaped the understanding of mpox transmission. These dogs are useful in studies as they are susceptible to infection, exhibit longer incubation periods, and can transmit the virus. Moreover, prairie dogs are the only small animals that develop the characteristic skin rash observed in human mpox cases. Non-human primates are also valuable, given the genetic proximity to and similar disease presentation as humans.

A study showed that experimentally inoculating through the upper respiratory tract of prairie dogs can establish the infection model. In 2013, respiratory transmission with clade I MPXV was demonstrated in prairie dogs. Transmission to naïve dogs was not detected with clade II MPXV. In the 1970s, studies on non-human primates also suggested respiratory transmission of MPXV.

Respiratory manifestations in humans

Severe respiratory distress has been observed in the late disease course with clade I MPXV infection. Oral lesions and oropharyngeal signs/symptoms have been reported historically and during the 2022 outbreak. A sore throat was commonly observed in up to 37% of cases in 2022. Cough was reported in nearly 50% of patients before 2022, but in 2022, it was less common, along with dyspnea and nasal congestion.

Historical and recent studies have described viral isolation from oral/respiratory anatomical sites. In a case series in the United Kingdom (UK), clade II MPXV DNA was isolated from the upper respiratory tract when respiratory symptoms were absent and even after the resolution of skin lesions. In some patients, viral shedding continued from the upper respiratory tract for over three weeks.

Mpox outbreaks in humans

Most research on mpox in humans before 2022 has been conducted in Africans. Close contact within households is implicated in long transmission chains spanning several generations. In the 2003 outbreak in the United States (US), all subjects with symptomatic mpox were in contact with prairie dogs or contaminated fomites.

Being near the infected animal was not associated with MPXV infection. Moreover, healthcare professionals were not infected, even when most reported inconsistent use of an N95 respirator or a surgical mask. The human-to-human transmission was documented during the mpox reemergence in Nigeria in 2017 in five individuals, including one healthcare worker and four incarcerated individuals.

During 2018-21, eight travelers from Nigeria to the US, UK, Israel, and Singapore were diagnosed with mpox. Four were symptomatic during the flight, and contact tracing identified no additional cases. Notably, the use of face masks during flights in 2021 as part of the public health measures against coronavirus disease 2019 (COVID-19) could have prevented respiratory transmission.  

In endemic regions, healthcare personnel are at a higher risk of infection than the general public. However, one study conducted in Colorado, US, in 2022 observed that healthcare workers exposed to mpox cases were not infected. Outbreak and clinical data showed that mpox transmission occurs during close contact for prolonged periods, and respiratory transmission between humans has not been reported in residential/congregate settings.

Concluding remarks

Together, the authors summarized the different kinds of evidence to understand the contribution of respiratory transmission to the spread of mpox. Respiratory symptoms and the isolation of viral DNA from the respiratory tract suggest transmission by the respiratory route but do not definitively reflect respiratory transmission.

Additionally, environmental surveillance studies observed replication-competent MPXV on surfaces and in the air, but the presence of the virus does not imply infectivity or transmission. Further, outbreak analyses with improved documentation of exposure histories could help determine the definitive transmission mode. So far, the odds of respiratory transmission appear low based on the available evidence, but studies should continue to assess this possibility.

Journal reference:
Tarun Sai Lomte

Written by

Tarun Sai Lomte

Tarun is a writer based in Hyderabad, India. He has a Master’s degree in Biotechnology from the University of Hyderabad and is enthusiastic about scientific research. He enjoys reading research papers and literature reviews and is passionate about writing.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sai Lomte, Tarun. (2023, March 13). Summarizing the evidence of respiratory transmission of mpox. News-Medical. Retrieved on April 15, 2024 from https://www.news-medical.net/news/20230313/Summarizing-the-evidence-of-respiratory-transmission-of-mpox.aspx.

  • MLA

    Sai Lomte, Tarun. "Summarizing the evidence of respiratory transmission of mpox". News-Medical. 15 April 2024. <https://www.news-medical.net/news/20230313/Summarizing-the-evidence-of-respiratory-transmission-of-mpox.aspx>.

  • Chicago

    Sai Lomte, Tarun. "Summarizing the evidence of respiratory transmission of mpox". News-Medical. https://www.news-medical.net/news/20230313/Summarizing-the-evidence-of-respiratory-transmission-of-mpox.aspx. (accessed April 15, 2024).

  • Harvard

    Sai Lomte, Tarun. 2023. Summarizing the evidence of respiratory transmission of mpox. News-Medical, viewed 15 April 2024, https://www.news-medical.net/news/20230313/Summarizing-the-evidence-of-respiratory-transmission-of-mpox.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research uncovers mechanical explanation for instability in the lungs of ARDS patients